Band 1
Provided by Tina Tai
Ms. Tai has more than 27 years' experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.
Ms. Tai is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) for Roche/Chugai, Victoza® (Liraglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.
Ms. Tai is well experienced with the communication with the courts and government authorities including CNIPA and NMPA for patent and drug regulatory issues.
Provided by Chambers
Tina Tai is a market veteran with three decades of experience in the IP space. Her expertise in patent invalidation matters is in high demand among pharmaceutical and healthcare companies.
Provided by Chambers
Tina excels at policy analysis, litigation and dispute resolution.
Tina is reputable and experienced in the pharmaceutical industry. She is easy to communicate with.
邰红律师擅长政策分析、诉讼和争议解决。
Tina在制药行业享有盛誉且经验丰富。她很好相处。
Tina excels at policy analysis, litigation and dispute resolution.
Tina is reputable and experienced in the pharmaceutical industry. She is easy to communicate with.
邰红律师擅长政策分析、诉讼和争议解决。
Tina在制药行业享有盛誉且经验丰富。她很好相处。
